Bg pattern

CHICLIDA 25 mg LOZENGES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CHICLIDA 25 mg LOZENGES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Chiclida 25 mg lozenges

Meclozine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist even if it is a side effect not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the package leaflet:

  1. What is Chiclida and what is it used for
  2. What you need to know before taking Chiclida
  3. How to take Chiclida
  4. Possible side effects
  5. Storage of Chiclida
  6. Contents of the pack and further information

1. What is Chiclida and what is it used for

Meclozine hydrochloride, the active substance of Chiclida, belongs to the group of medicines called antihistamines, used against motion sickness.

Chiclida is indicated for the prevention and treatment of symptoms of motion sickness caused by land, sea, or air travel, such as nausea, vomiting, and/or vertigo in adults and adolescents over 12 years of age.

You should consult a doctor if it worsens or does not improve after 7 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Chiclida

Do not take Chiclida

  • If you are allergic to Meclozine hydrochloride or to any of the other components of this medicine (listed in section 6).
  • If you have increased intraocular pressure (glaucoma).
  • If you have prostate enlargement (prostatic hypertrophy).
  • If you have a disease that causes obstruction of the gastrointestinal or urinary tract.
  • If you have asthma.
  • If you have diabetes.
  • Children under 6 years of age.

Warnings and precautions

Consult your doctor or pharmacist before taking Chiclida:

  • If you have seizures with convulsive movements, with or without loss of consciousness (epilepsy).
  • If you are over 65 years old, dry mouth, urinary retention, glaucoma, nausea, dizziness, sedation, confusion, low blood pressure (hypotension), or hyperexcitability may occur.
  • If you are taking any medication that causes ear toxicity, as symptoms of these toxic effects, such as ringing in the ears, dizziness, or vertigo, may be masked.
  • If you have any liver or kidney disease or disorder, as the concentration of the active substance may increase.
  • If you have any heart disease or disorder, such as cardiac arrhythmia, hypertension, severe muscle weakness (myasthenia gravis), stomach or intestinal ulcers.
  • If you suspect you have symptoms of appendicitis, such as nausea, vomiting, or abdominal cramps. It is recommended to consult a doctor to rule out the presence or absence of appendicitis.

Avoid exposure to the sun while taking this medicine.

If you are allergic to any other antihistamine, it is not recommended to take this medicine.

Interference with laboratory tests

If you are going to have a skin test that uses allergens, inform your doctor that you are taking this medicine, as it may alter the results.

It is recommended to stop taking this medicine at least 72 hours before the test.

Children

Do not use this medicine in children under 12 years of age.

Using Chiclida with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.

The following are not recommended to be taken in combination with Chiclida:

  • Central nervous system depressants, such as anesthetics, opioid analgesics, barbiturates (used as sedatives, anticonvulsants, and for sleep disorders), benzodiazepines (for sleep), antipsychotics.
  • Antiparkinsonian medicines.
  • Antidepressants.
  • Neuroleptics (used to calm excitement and neuromuscular hyperactivity).

Taking Chiclida with food, drinks, and alcohol

Alcoholic beverages may enhance the effect of Meclozine, so it is not recommended to take them simultaneously.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.

It should not be used during pregnancy, unless strictly necessary. Do not administer during breastfeeding.

Driving and using machines

Chiclida may cause drowsiness, which may affect your ability to drive and/or operate machines. Patients should avoid operating hazardous machinery, including automobiles, until they know how they tolerate the medicine.

Chiclida contains glucose and sucrose

This medicine contains glucose and sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

It may cause tooth decay.

3. How to take Chiclida

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor. In case of doubt, ask your doctor or pharmacist.

Adults and adolescents (over 12 years of age): 1 or 2 lozenges of Chiclida (25 mg - 50 mg meclozine hydrochloride) approximately 1 hour before starting the trip. If necessary, repeat the dose every 24 hours. Do not exceed the dose of 2 lozenges of Chiclida (50 mg of meclozine hydrochloride) per day.

Patient with renal and/or hepatic insufficiency: It may be necessary to reduce the dose (see section 2 Warnings and precautions).

Suck the lozenge. Do not swallow.

Administer at least 1 hour before starting the trip.

If the symptoms worsen or persist for more than 7 days, you should consult a doctor.

Use in children

Chiclida is contraindicated in children under 6 years of age.

It is not recommended to administer this medicine to children between 6 and 12 years of age.

If you take more Chiclida than you should

You should consult your doctor or pharmacist immediately.

The symptoms of an overdose may vary, from sedation, difficulty breathing, loss of consciousness to insomnia, hallucinations, tremors, or convulsions.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Chiclida

Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you think any of the side effects you are experiencing are serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

If you have a severe allergic reaction (anaphylactic shock) with rash, itching, difficulty breathing, stop taking the medicine and seek medical help immediately.

The most common side effects are drowsiness and sedation. Dry mouth, blurred vision, nausea, vomiting, and joint pain occur rarely (may affect up to 1 in 1,000 patients).

Other side effects of unknown frequency (cannot be estimated from the available data) are:

  • Abdominal pain, diarrhea, and constipation.
  • Sleepiness and sedation.
  • Increased bronchial secretion.
  • Increased appetite, anorexia.
  • Anxiety, euphoria, irritability, hallucinations, insomnia, memory disorders, psychotic disorders, confusion, and paranoia.
  • Dizziness, headache, movement disorders (e.g., Parkinson's disease), paresthesia (tingling and numbness sensation).
  • Double vision.
  • Vertigo, tinnitus (internal ear noises).
  • Dry throat and nose, bronchospasm (contraction of the bronchi), epistaxis (nosebleed).
  • Dysuria (difficult, painful, and incomplete urination), polyuria (production and excretion of large amounts of urine), urinary retention.
  • Fatigue, weakness.
  • Tachycardia, palpitations, and/or arrhythmias.
  • Hypotension (decreased blood pressure).
  • Hyperexcitability may occur, especially in children.
  • Decrease in the number of red blood cells, white blood cells, leukocytes, and platelets in the blood.
  • Allergic reactions on the skin and sensitivity to sunlight, after intense exposure, which may cause itching and redness of the skin.
  • Weight gain.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Chiclida

No special storage conditions are required.

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition of Chiclida

The active substance is Meclozine hydrochloride. Each lozenge contains 25 mg of meclozine hydrochloride.

The other ingredients are: glucose monohydrate, sucrose, peppermint flavor, and magnesium stearate. See section 2 "Chiclida contains glucose and sucrose".

Appearance of the product and pack contents

Oval-shaped lozenges, white in color.

Each pack contains 6 lozenges.

Marketing authorization holder and manufacturer

Marketing authorization holder

Name: Fleer Española, S.L.

Address: Rambla Catalunya Nº. 53 ático

City: 08007-Barcelona

Manufacturer:

Name: Fleer Española, S.L.

Address: 08795 – Olesa de Bonesvalls (Barcelona) Phone: 93 898 40 11 Fax: 93 898 41 76

Date of the last revision of this leaflet: January 2015

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)

http://aemps.gob.es

Online doctors for CHICLIDA 25 mg LOZENGES

Discuss questions about CHICLIDA 25 mg LOZENGES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (144)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for CHICLIDA 25 mg LOZENGES?
CHICLIDA 25 mg LOZENGES does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CHICLIDA 25 mg LOZENGES?
The active ingredient in CHICLIDA 25 mg LOZENGES is meclozine. This information helps identify medicines with the same composition but different brand names.
Who manufactures CHICLIDA 25 mg LOZENGES?
CHICLIDA 25 mg LOZENGES is manufactured by Fleer Española S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CHICLIDA 25 mg LOZENGES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CHICLIDA 25 mg LOZENGES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CHICLIDA 25 mg LOZENGES?
Other medicines with the same active substance (meclozine) include CHICLIDA 25 mg MEDICATED CHEWING GUMS, ALERCINA 10 mg TABLETS, ALERLISIN 1 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media